ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674066 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674066; 2) Community: the network communities that were significantly associated with the response to NSC 674066; 3) Molecule: the relationships between components within communities and NSC 674066; 4) MDR: the compounds that were significantly associated with the NSC 674066.

NSC Compound Enrichment Correlation
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.0181211508101519 0.41832886
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0181211508101519 0.20773587
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0181211508101519 0.50021109
NSC 758664 Sirolimus [USAN] 0.0181211508101519 -0.28115951
NSC 758682 ARTENIMOL 0.0181211508101519 0.3743802
NSC 48856 Null 0.0185619722391416 0.20254019
NSC 613662 Null 0.0185619722391416 0.45282078
NSC 629730 Null 0.0185619722391416 0.4703883
NSC 694484 4-[N-(4-amino-4-deoxy-N10-methylpteroyl)aminobutanoic acid 0.0185619722391416 0.30883894
NSC 694610 2,3-Dihydro-2,3-dihydroxy-brefeldin A 0.0185619722391416 0.14663304
Total:118  Current:61    [First] [Prev] [Next] [Last]